Skip to main content

Peer Review reports

From: T-DM1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis

Original Submission
15 Jun 2021 Submitted Original manuscript
20 Oct 2021 Reviewed Reviewer Report
18 Nov 2021 Reviewed Reviewer Report
4 Mar 2022 Author responded Author comments - Claudia Omarini
Resubmission - Version 2
4 Mar 2022 Submitted Manuscript version 2
28 Mar 2022 Reviewed Reviewer Report
28 Mar 2022 Reviewed Reviewer Report
11 Apr 2022 Author responded Author comments - Claudia Omarini
Resubmission - Version 3
11 Apr 2022 Submitted Manuscript version 3
Publishing
17 Apr 2022 Editorially accepted
7 Jun 2022 Article published 10.1186/s12885-022-09556-7

You can find further information about peer review here.

Back to article page